Press releases

Acquisition allows Boston Scientific to offer a more complete portfolio of solutions to treat challenging vascular conditions

Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure

Boston Scientific will participate in the healthcare conference on September 8 in New York

Companies reach agreement to develop a new and differentiated FFR guidewire and next generation Boston Scientific Rotablator™ RotaWire™

"We had a strong second quarter, delivering balanced growth across our divisions," said CEO Mike Mahoney

Innovative technology adds to company's leading portfolio of treatment options for Coronary Artery Disease

Easy to use imaging system to support planned intravascular ultrasound and fractional flow reserve products

Advanced bare-metal stent provides additional treatment option for interventional cardiologists and patients

European launch means physicians can now choose from three available valve sizes to match patient anatomy more precisely

Innovative technology strengthens company's leading portfolio of solutions for peripheral vascular disease